Injection of a soluble protein factor from mammalian spermatozoa triggers Ca 2+ oscillations in mammalian eggs similar to those seen at fertilization. This sperm factor also generates inositol 1,4,5-trisphosphate and causes Ca 2+ release in sea urchin egg homogenates and frog eggs. Recent studies have indicated that the sperm factor may be an inositol-specific phospholipase C (PLC) activity. This study investigated whether any of the commonly known PLC isoforms are components of the sperm factor. PLCβ, PLCγ and PLCδ isoforms were shown to be present in boar sperm extracts. However, upon column fractionation of sperm extracts, none of the PLC isoforms detected correlated with the ability to cause Ca 2+ release in eggs. In addition to our previous work on recombinant PLCs, it was also shown that PLCδ3, PLCδ4 and its splice variant PLCδ4 Alt1 fail to cause Ca 2+ release. The recently discovered 255 kDa PLCε isoform also appears unlikely to be a component of the sperm factor, as fractionation of sperm extracts on a gel filtration column demonstrated that the peak of Ca 2+ -releasing activity was associated with fractions of 30-70 kDa. These findings indicate that the sperm factor that triggers Ca 2+ release in eggs does not appear to have a known PLC isoform as one of its components.
Introduction
At fertilization, egg activation is triggered by a sperminduced increase in intracellular Ca 2+ (Nuccitelli, 1991; Whitaker and Swann, 1993; Stricker, 1999) . In all vertebrate eggs and in eggs of many other species, the Ca 2+ increase is a result of Ca 2+ release from intracellular stores (Stricker, 1999) . Phosphatidylinositol signalling is implicated in this process, as increased inositol 1,4,5-trisphosphate (InsP 3 ) production occurs at fertilization in sea urchin and frog eggs (Turner et al., 1984; Nuccitelli, 1991) , whereas blocking InsP 3 receptors in hamster and mouse eggs inhibits Ca 2+ release at fertilization (Miyazaki et al., 1993) . However, the mechanism by which the spermatozoon induces Ca 2+ release in the egg remains unresolved.
One theory of egg activation proposes that a surface interaction between a sperm ligand and an egg receptor leads to stimulation of an egg PLCβ or PLCγ via either a G protein or a tyrosine kinase pathway, respectively (Jaffe, 1990; Schultz and Kopf, 1995; Evans and Kopf, 1998) . The finding that injection of SH2 domains of PLCγ can block Ca 2+ release and egg activation in starfish, sea urchin and ascidian eggs indicates an essential role for an egg-derived PLCγ (Carroll et al., 1997 (Carroll et al., , 1999 Shearer et al., 1999; Runft and Jaffe, 2000) . However, injection of SH2 domains or G protein inhibitors does not block Ca 2+ release in frog or mouse eggs (Williams et al., 1998; Runft et al., 1999) . The identities of the receptors that may link sperm binding to egg activation in vertebrate eggs also remain unknown (Wassarman et al., 2001) .
Another explanation of how eggs are activated at fertilization proposes that Ca 2+ release is triggered by a soluble sperm factor that enters the egg at gamete fusion (Whitaker and Swann, 1993; Fissore et al., 1998; Swann and Parrington, 1999; Parrington, 2001 ). This hypothesis is supported by the finding that injection of soluble sperm extracts from boars, hamsters or humans can trigger Ca 2+ oscillations in mouse, hamster, human and cow eggs similar to those seen at fertilization (Swann, 1990 (Swann, , 1994 Homa and Swann, 1994; Palermo et al., 1997; Wu et al., 1997; Fissore et al., 1998) . There is also evidence for a sperm factor in marine worms (Stricker, 1997) , ascidians (Kyozuka et al., 1998; McDougall et al., 2000; Runft and Jaffe, 2000) and newts (Yamamoto et al., 2001 ). The sperm factor activity is effective across different animal phyla because sperm extracts from frogs and chickens trigger Ca 2+ oscillations when injected into mouse eggs (Dong et al., 2000) and boar sperm extracts trigger Ca 2+ oscillations in eggs of nemertean worms (Stricker et al., 2000) . The sperm factor appears to be a protein or proteins that may be sperm-specific, as the Phospholipase C isoforms in mammalian spermatozoa: potential components of the sperm factor that causes Ca 2+ release in eggs ability to trigger Ca 2+ oscillations in eggs is not found in extracts from other tissues (Swann, 1990; Stricker, 1997; Wu et al., 1997; Parrington et al., 2000) . The molecular identity of the sperm factor protein is currently unknown. It has been suggested that it is made up of a variety of different proteins such as a 33 kDa glucosamine deaminase, a truncated form of the c-kit receptor, a perinuclear protein or a nitric oxide synthetase (Parrington et al., 1996; Sette et al., 1997 Sette et al., , 1998 Kuo et al., 2000) . However, none of these candidates now seems likely to be a component of the sperm factor (Wolsoker et al., 1998; Wu et al., 1998; Parrington et al., 1999; Hyslop et al., 2001) . Recent studies on the mammalian sperm factor protein have made use of sea urchin egg homogenate, a cell-free system that undergoes specific Ca 2+ release in response to intracellular Ca 2+ -releasing agents including InsP 3 (Lee, 1997). The same factor that is active in causing Ca 2+ oscillations in eggs is able to cause Ca 2+ release in sea urchin egg homogenates and this release is associated with the production of InsP 3 (Jones, 1998; Parrington et al., 1999) . The sperm factor also causes Ca 2+ release in frog eggs via the generation of InsP 3 (Wu et al., 2001) . Data from homogenates also show that the ability of fractionated sperm extracts to cause Ca 2+ release in eggs correlates with a PLC activity that can hydrolyse phosphatidylinositol 4,5-bisphosphate (PIP 2 ) at low Ca 2+ concentrations J. Parrington and K. Swann, unpublished) . This finding indicates that the sperm factor contains a PLC activity. This sperm PLC activity is two orders of magnitude greater than PLC activities in other tissues and appears to be present in sufficient amounts in a single spermatozoon to account for the Ca 2+ release observed at fertilization (Rice et al., 2000) . The ability of the PLC to cause InsP 3 production in egg homogenates also indicates that it has distinctive properties (Jones et al., 1998 Parrington et al., 1999; Rice et al., 2000) .
Which PLC isoform constitutes the active component of the mammalian sperm factor needs to be addressed. There are now four known major classes of PLC (Rhee, 2001 ): PLCβ (with four subtypes), PLCγ (with two subtypes), PLCδ (with four subtypes) and PLCε. PLCβ and PLCγ isoforms have a molecular mass of 140-150 kDa, PLCδ isoforms are 85-90 kDa and the PLCε isoform is 255 kDa. The PLCβ1, PLCγ1 and PLCγ2 isoforms have been detected in mouse spermatozoa (Walensky and Snyder, 1995; Dupont et al., 1996; Tomes et al., 1996; Mehlmann et al., 1998 ). PLCδ1 appears to be expressed in mouse spermatogonia (Lee et al., 1999) and some splice variants of PLCδ4 appear to be testes-specific (Lee and Rhee, 1996; Nagano et al., 1999) . The aim of the present study was to investigate whether one of the known PLC isoforms is the active component of the mammalian sperm factor. Immunoblot analysis was used to identify which PLC isoforms are present in mammalian sperm extracts. The presence of the different known PLC isoforms in mammalian sperm extracts and subfractions that cause Ca 2+ release in mouse eggs and sea urchin egg homogenates was investigated. The Ca 2+ -releasing properties of recombinant PLCδ3, together with PLCδ4 and one of its splice variants, were also assessed. Finally, fractionation by gel filtration was used to determine the molecular mass of the sperm PLC activity.
Materials and Methods

Reagents
All chemicals were from Sigma (Poole) unless stated otherwise. Rabbit polyclonal antibodies raised against peptides specific to PLCβ (1-4), PLCγ (1 and 2), PLCδ (1 and 2) were from Santa Cruz Biotechnology (Santa Cruz, CA). A rabbit polyclonal antibody to PLCδ4 was a generous gift from K. Fukami (University of Tokyo, Tokyo). Anti-rabbit peroxidase-conjugated polyclonal antibody was from DAKO (Cambridge). Immunoblots were developed with an enhanced chemiluminescence system (Amersham Pharmacia Biotech, Little Chalfont). Chromatography was performed on an AKTA FPLC system with a MonoS column and a Superdex 200 gel filtration column (Amersham Pharmacia Biotech).
Preparation of spermatozoa and sperm extracts Boar, mouse, rat and hamster spermatozoa were washed three times in PBS. Pelleted spermatozoa (centrifuged for 1 min at 2000 g) were measured for amount of protein and were used fresh for SDS-PAGE analysis. Boar, mouse, rat and hamster sperm extracts were prepared by a freeze-thaw method as described by Jones et al. (1998) . Sperm extracts were frozen in liquid nitrogen and stored at -80ЊC.
SDS-PAGE and immunoblot analysis
Whole tissue and tissue extracts were prepared for immunoblot analysis by addition to SDS-PAGE sample buffer and boiling for 5 min before loading on to an SDS-PAGE gel. Protein concentrations were measured using a bicinchononic acid protein assay (Sigma, Poole). SDS-PAGE and immunoblot analysis were performed as described by Parrington et al. (1996 Parrington et al. ( , 1999 . For the PLCδ1 immunoblot, an enrichment step was carried out before SDS-PAGE. In brief, protein was incubated with 50 µl heparin Sepharose in a total volume of 500 µl PBS for 2 h at 4ЊC. The beads were pelleted by centrifugation at 2000 g for 1 min and washed three times with 1 ml cold PBS. After the final wash, the drained beads were added to 4 ϫ SDS-PAGE loading buffer and boiled for 10 min. After pelleting the beads, 15 µl of the supernatant was loaded on to a 10% SDS-PAGE gel and subjected to immunoblotting as described above. In all cases the immunoblots were developed with the enhanced chemiluminescence system (Amersham Pharmacia Biotech).
Chromatographic fractionation
A MonoS column was loaded with 6.5 mg boar sperm extract in 250 mmol KCl l -1 , 20 mmol 2-(Nmorpholino)ethanesulphonic acid (MES) l -1 , pH 6, and eluted with increasing salt up to 1 mol KCl l -1 to fractionate boar sperm extract. The most active fraction from the MonoS column was loaded on to a Superdex 200 gel filtration column in 150 mmol NaCl l -1 , 50 mmol sodium phosphate l -1 , pH 7.0, to ascertain the molecular mass of the sperm factor. An identical gel filtration fractionation was carried out with native molecular mass standards to calibrate the column. For fractionation of hamster sperm extract, a MonoS column was loaded with 5 mg hamster sperm extract in 100 mmol KCl l -1 in the same buffer and eluted with increasing salt up to 1 mol KCl l -1 . In each case, fractions were pooled, concentrated on Centricon C-30 concentrators (Millipore, Watford), washed and adjusted to the same protein concentration of 20 mg ml -1 by dilution with 120 mmol KCl l -1 and 20 mmol Hepes l -1 , pH 7.5.
Ca 2+ release assays
Unfertilized sea urchin (Lytechinus pictus) egg homogenates (2.5%) (Marinus Inc., Long Beach, CA) were prepared as described by Jones et al. (1998) using fluo-3 (3 µmol l -1 ) fluorescence as an indicator of Ca 2+ release. For all assays of Ca 2+ release, 2 µl of each fraction, previously adjusted to the same protein concentration, was added to 0.5 ml samples of homogenate (Jones et al., 1998; Parrington et al., 1999) . Mouse eggs were collected from superovulated female MF1 mice and maintained in M2 medium. Microinjections and Ca 2+ changes were carried out as described by Swann (1990) .
Recombinant proteins
Recombinant versions of PLCδ3, PLCδ4 and PLCδ4 Alt1 were created. A construct containing the PLCδ3 full-length cDNA was a generous gift from J. Knopf (Genetics Institute, Cambridge). RT-PCR of rat spermatogenic cell mRNA generated PLCδ4 Alt1 and Alt2 splice variants, together with normal PLCδ4 sequence. These were identified by sequence analysis (MWG Biotech, Milton Keynes). The PLCδ3 sequence was subcloned into a pGEX-2T vector (Amersham Pharmacia Biotech) so that it was expressed as a glutathione S-transferase (GST) fusion protein. The PLCδ4 sequences were cloned into a pMAL-2X vector (New England Biolabs, Beverly) so that they were expressed as maltose binding protein (MBP) fusion proteins. Further sequence analysis was used to verify that the PLC fusion constructs were in the correct frame. These constructs were transfected into BL21 E. coli cells (Invitrogen, Groningen) and protein expression was induced by treatment with isopropyl β-D-thiogalactopyranoside (0.2 mmol l -1 ) and protein expressed at 18-20ЊC for 16-18 h. Lysates were prepared by sonicating the bacterial pellet in lysis buffer. In the case of the GST-PLCδ3 construct, the lysis buffer was PBS supplemented with 1 mmol EDTA l -1 , 1 mmol dithiothreitol (DTT) l -1 and complete protease inhibitors (Roche, Lewes); in the case of the MBP-PLCδ4 constructs, the lysis buffer was 25 mmol Hepes l -1 , 200 mmol NaCl l -1 , 1 mmol EDTA l -1 , 1 mmol DTT l -1 , 2 mmol 4-(2-aminoethyl)benzenesulphonyl fluoride l -1 and complete protease inhibitors (Roche). Resuspended cells were sonicated in three 30 s bursts. Lysates were clarified by centrifugation at 12 000 g for 10 min. The recombinant proteins were purified according to the appropriate manufacturer's protocol. In brief, GST-PLCδ3 was purified by binding to glutathione-sepharose beads (Amersham Pharmacia Biotech) and elution with 10 mmol reduced glutathione l -1 in 50 mmol Tris l -1 , pH 8, whereas the MBP-PLCδ4 proteins were purified by binding to amylose resin (New England Biolabs) and elution with PBS containing 10 mmol maltose l -1 . After purification, recombinant proteins were buffer-exchanged into 20 mmol Hepes l -1 , 120 mmol KCl l -1 , pH 7.5, using a Sephadex G-25 column (Amersham Pharmacia Biotech) and concentrated using a Vivaspin 8 ml concentrator (Sartorius, Epsom) to a protein concentration of 8-10 mg ml -1 . Concentrated protein was divided into aliquots and stored at -80ЊC until required.
Results
Detection and assessment of PLCβ, PLCγ and PLCδ isoforms in mammalian spermatozoa and sperm extracts
Immunoblot analysis was used to identify which PLCβ and PLCγ isoforms are present in boar sperm extracts. Proteins of the expected molecular mass (140-150 kDa) were detected in sperm extracts with antibodies to PLCγ1 and PLCβ2 (Fig. 1a) , whereas with an antibody to PLCγ2, a protein of the expected size was detected in spermatozoa but not in sperm extracts. All the antibodies detected proteins of the expected molecular mass in boar brain (Fig.  1b) . In sperm extracts, proteins of lower than expected molecular mass were also detected. Most notably, antibodies to PLCβ1 and PLCβ4 reacted with proteins of approximately 115 kDa and 70 kDa, respectively (Fig. 1a) . Sperm extracts were fractionated on a MonoS cationic exchange column and the presence of PLC isoforms in the separated fractions was assessed using immunoblot analysis (Fig. 2a) to determine whether any of the putative PLC isoforms correlated with ability to trigger Ca 2+ release in eggs. The bulk of the protein in the sperm extract appeared in the flow through fraction (Fig. 2a, i ) but this fraction had no Ca 2+ -releasing activity in intact eggs or egg homogenates (Fig. 2a, ii and iii) . Ca 2+ -releasing activity was found only in fractions D and E (Fig. 2a, i and ii). Immunoblot analysis with antibodies specific to PLCβ1, PLCβ2, PLCβ4 and PLCγ1 revealed that the proteins recognized by these antibodies were found only in the inactive flow through and not in the active fraction D (Fig. 2b) . These data show that the PLCβ and PLCγ isoforms that are present in mammalian spermatozoa are unlikely to form part of the sperm factor that triggers Ca 2+ release in eggs.
The PLCδ isoforms were also investigated as candidate sperm factors. Immunoblot analysis with an antibody against PLCδ1 showed that an 85 kDa protein corresponding to full-length PLCδ1, and a related breakdown product of 68 kDa, could be detected in brain, kidney, liver and testes extracts, but could not be detected in sperm extracts (Fig. 3a, i) . A similar comparison using an antibody against PLCδ2 indicated the presence of a protein of the expected molecular mass (85 kDa) in testes, which appeared to be present in high concentrations compared with amounts in other tissues (Fig. 3a, ii) . This protein was also present in soluble sperm extracts (Fig. 3a, iii) . However, upon fractionation of boar sperm extracts in a manner similar to that shown earlier (Fig. 2a) , the 85 kDa protein recognized by the antibody to PLCδ2 was found in the inactive flow through fraction A, and not in fraction D which contained Ca 2+ -releasing activity (Fig. 3a, iii) . A protein of approximately 18 kDa in fraction D that was recognized by the anti-PLCδ2 antibody was found by Nterminal protein sequencing to be unrelated to PLCδ2 (data not shown).
An antibody against PLCδ4 failed to recognize a protein of the expected molecular mass in boar sperm extract (data not shown). However, in mice, rats and hamsters, PLCδ4 was found to be expressed in brain and spermatozoa, and was highly expressed in mouse and rat spermatozoa compared with expression in hamster spermatozoa (Fig. 3b,  i) . Further analysis showed that the PLCδ4 protein in mouse and rat spermatozoa is 3 kDa larger than that in the brain (Fig. 3b, ii) , indicating that the PLCδ4 in spermatozoa could be the Alt1 splice variant (Lee and Rhee, 1996) . Hamster sperm extracts were used to determine whether the presence of PLCδ4 was associated with Ca 2+ -releasing activity. Immunoblot analysis indicated that PLCδ4 was present only in the membrane pellet and not in the soluble fraction (Fig. 4a) . Fractionation of hamster extract on a MonoS column showed that none of the lower molecular mass proteins recognized by the anti-PLCδ4 antibody correlated with Ca 2+ -releasing activity (Fig. 4b) . These data, and those above, indicate that the PLCδ2 and PLCδ4 isoforms are not components of the sperm factor in mammalian spermatozoa.
Ca 2+ -releasing properties of recombinant PLCδ3 and PLCδ4 isoforms
As a further test of the possibility that a known PLC may contribute to the sperm factor, the activity of recombinant PLCδ3 and PLCδ4 was tested in our cell-free system. It has already been shown that recombinant PLCβ1, PLCγ1, PLCδ2 and PLCδ1 fail to cause Ca 2+ release in sea urchin egg homogenates . In this study, recombinant PLCδ3, PLCδ4 and PLCδ4 Alt1 proteins were prepared. An antibody to PLCδ4 recognizes recombinant PLCδ4 and PLCδ4 Alt1; PLCδ4 is 3 kDa larger than PLCδ4 Alt1 (Fig. 5a) . Although a diluted boar sperm extract caused Ca 2+ release in homogenate, the recombinant PLCδ3, PLCδ4 and PLCδ4 Alt1 failed to cause Ca 2+ release (Fig.  5b,c) . The lack of effect of recombinant PLCs was not due to lack of enzymatic activity because when the recombinant PLCs were pre-incubated with PIP 2 , and the homogenate used as an assay of IP 3 generation (Jones et al., 1998) , the recombinant PLCδ3, PLCδ4 and PLCδ4 Alt1 had similar or greater PLC activity than did the diluted boar sperm extract (Fig. 5c ).
Size fractionation of boar sperm PLC activity PLCε, for which antibodies were unavailable, has a molecular mass of 255 kDa, whereas other known PLC isoforms range in size from 85-90 to 140-150 kDa (Rhee, 2001) . The molecular mass of the sperm factor was investigated by gel filtration chromatography. The active fraction D from a MonoS fractionation (Fig. 2a) was loaded on to a Superdex 200 gel filtration column and fractions were assayed for Ca 2+ -releasing activity in sea urchin egg homogenates. Upon comparison with native molecular mass standards, the peak of activity was found in a fraction corresponding to a molecular mass range of 29-70 kDa (Fig. 6b,c) . A Coomassie-stained SDS-PAGE gel of the same fractions showed that most of the proteins eluted at the expected molecular mass (data not shown). This result is similar to that in a previous study, which found that the sperm factor active in causing Ca 2+ oscillations in mouse eggs had a molecular mass in the range 29-70 kDa (Wu et al., 1998) .
Discussion
The results from the present study show that a number of PLCβ, PLCγ and PLCδ isoforms can be detected in mammalian spermatozoa. However, none of the common versions of the PLC subtypes detected in spermatozoa or sperm extracts appears to be a component of the soluble sperm factor that causes Ca 2+ release in eggs. There are two lines of evidence that support this conclusion. Firstly, the known full-length isoforms of PLC do not correlate with the ability of extracts to cause Ca 2+ release in intact eggs or in egg homogenates. Removal of all these isoforms in combination, through fractionation, also excludes the possibility that the sperm factor activity consists of these isoforms acting in tandem. These results from a wide set of PLCs are consistent with a recent study, which looked at a more limited subset of isoforms in spermatozoa (PLCγ1, PLCγ2 and PLCδ4) and found no evidence that the isoforms correlated with the sperm factor activity in intact mouse eggs (Wu et al., 2001) . The PLCδ4 isoform is also an unlikely candidate for the mammalian sperm factor because spermatozoa from knockout mice that lack the PLCδ4 isoforms (and its splice variants) possess Ca 2+ -releasing activity (Fukami et al., 2001) . The other line of evidence against the known PLCβ, PLCγ or PLCδ isoforms as a component of the sperm factor is that none of the common isoforms tested, in either this study or in previous reports , is able to trigger Ca 2+ release in eggs. The only isoform that was not tested in the present study is the newly described ε subtype of PLC (Song et al., 2000; Kelley et al., 2001; Rhee, 2001 ). This subtype of PLC has a molecular mass of 255 kDa, which is much greater than the apparent molecular mass (30-70 kDa) found for the sperm factor in the current study. This finding indicates that the PLCε isoform is also unlikely to be a component of the mammalian sperm factor. With the caveat that some proteins elute differently from their predicted molecular mass, this gel filtration profile also indicates that the sperm factor has a molecular mass most similar to a PLCδ. It also makes it unlikely that the sperm factor is a complex of several PLCs.
There are several possible interpretations of the inability to correlate the sperm factor protein with any of the known isoforms of PLC. One possibility is that the sperm factor that causes Ca 2+ release in mammalian eggs is an alternative type of enzyme (Kuo et al., 2000; Runft and Jaffe, 2000; Wu et al., 2001 ). However, this possibility is unlikely because the ability of sperm extracts to cause Ca 2+ release in eggs is associated with the production of InsP 3 and with a highly active PLC that is present in sperm extracts (Jones et al., 1998 Rice et al., 2000) . One interpretation of our current data is that mammalian sperm extracts contain an unidentified PLC activity. Whatever the nature of the sperm PLC activity, it is clearly distinctive in possessing an unusual capacity to cause Ca 2+ oscillations in mouse eggs and Ca 2+ release in sea urchin egg homogenates, which is not mimicked by recombinant versions of PLCβ1, PLCγ1, PLCγ2 and PLCδ1 . The recombinant PLCδ3 and PLCδ4 (together with its splice variant Alt1) also fail to mimic the properties of the sperm extract PLC activity.
If the sperm factor is a PLC, despite data from the current study, there are two more possible explanations. One is that the sperm PLC is a shortened or truncated form of a known PLC isoform that is not recognized by the panel of antibodies currently being used. Most of the antibodies react with peptides in the C-terminal region of the known PLCs and if this region were absent in a sperm-related form it would not be detected. Association of a truncated sperm PLC with other accessory proteins might also confer a difference in activity that could explain why the recombinant PLCs fail to cause Ca 2+ release in eggs . Future studies could address this possibility by using antibodies raised against internal regions of PLC isoforms. The other possibility is that sperm extracts contain a novel PLC isoform. This isoform could be sufficiently different from the known forms such that the current antibodies would fail to detect it. Such a novel PLC isoform would be of a relatively small molecular mass (in the range close to 70 kDa) to be consistent with the current data. The presence of a number of PLC isoforms in boar and rodent spermatozoa and testis raises the question of the function of the PLC isoforms in spermatozoa. PLCβ1 may be involved in the acrosome reaction, as a 115 kDa protein recognized by an antibody to PLCβ1 and G q and G 11 colocalizes to the acrosomal region of mouse spermatozoa (Walensky and Synder, 1995) and progesterone-stimulated diacyl glycerol (DAG) formation is not blocked by pertussis toxin (Murase and Roldan, 1996) . Why PLCβ1 in mouse spermatozoa appears smaller than its expected molecular mass is not clear, but in the present study in boar spermatozoa a 115 kDa protein was detected with an antibody against PLCβ1. In brain extracts, the presence of a similar sized fragment of PLCβ1 was due to proteolysis by calpain (Park et al., 1993) . The acrosome reaction may also involve a PLC activated by a pertussis toxin-sensitive G protein (Go or Gi type) as DAG formation triggered by zona pellucida is blocked by pertussis toxin (Murase and Roldan, 1996) and activation of Gi has been demonstrated after stimulation of mouse spermatozoa with zona pellucida (Ward et al., 1994) . In this context, it is interesting that PLCβ2 has been found in boar spermatozoa, as activation of PLCβ2 by βγ subunits may be an important route by which pertussis toxin-sensitive G proteins stimulate PLCs (Camps et al., 1992; Katz et al., 1992) .
Previous studies of the role of phosphatidylinositol signalling proteins in sperm processes have tended to focus on the PLCβ and PLCγ isoforms. The finding in the present study that PLCδ1 is apparently present in high concentrations in testes extract but not in sperm extract is in line with a previous immunohistochemical study in which PLCδ1 was found to be expressed in the spermatogonia (Lee et al., 1999) . The presence of PLCδ2 at high concentrations in spermatozoa compared with those in other tissues is a novel finding and indicates a specific function. Data showing that rodent spermatozoa contain the PLCδ4 splice variant PLCδ4 Alt1 also indicate a specialized spermspecific role for this isoform. Lee and Rhee (1996) reported that the Alt1 isoform is testes-specific, but it was not clear whether the protein was present in the spermatozoa, another type of testicular cell or in a type of cell at an earlier stage of spermatogenesis. A recent study detected only the Alt2 isoform in mouse spermatozoa, which appeared to be involved in the acrosome reaction (Fukami et al., 2001) . It is possible that spermatozoa contain several PLCδ4 splice variants that fulfil different functions.
